Rana Jahanban-Esfahlan (Rana Jahanban Esfahlan)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Hyaluronic Acid

Herpes Simplex Virus

Walled Carbon Nanotubes

Top Venues

Advanced pharmaceutical bulletin

Biomedical materials (Bristol, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Masumeh Kaveh Zenjanab, Nastaran Hashemzadeh, Sajjad Alimohammadvand, Masoumeh Sharifi-Azad, Elaheh Dalir Abdolahinia, Rana Jahanban-Esfahlan
Notch Signaling Suppression by Golden Phytochemicals: Potential for Cancer Therapy. Advanced pharmaceutical bulletin 14 (2) (2024)
Masoumeh Sharifi-Azad, Masumeh Kaveh Zenjanab, Mohammad Shahpouri, Mohammad Amin Adili-Aghdam, Marziyeh Fathi, Rana Jahanban-Esfahlan
Codelivery of methotrexate and silibinin by niosome nanoparticles for enhanced chemotherapy of CT26 colon cancer cells. Biomedical materials (Bristol, England) (2024)
Masoumeh Kaveh Zenjanab, Elaheh Dalir Abdolahinia, Effat Alizadeh, Hamed Hamishehkar, Rasoul Shahbazi, Zahra Ranjbar-Navazi, Rana Jahanban-Esfahlan, Marziyeh Fathi, Seyed Abolghasem Mohammadi
Hyaluronic Acid-Targeted Niosomes for Effective Breast Cancer Chemostarvation Therapy. ACS omega 9 (9) (2024)
Masoumeh Kaveh Zenjanab, Elaheh Dalir Abdolahinia, Effat Alizadeh, Hamed Hamishehkar, Rasoul Shahbazi, Zahra Ranjbar-Navazi, Rana Jahanban-Esfahlan, Marziyeh Fathi, Seyed Abolghasem Mohammadi
Hyaluronic Acid-Targeted Niosomes for Effective Breast Cancer Chemostarvation Therapy. ACS omega 9 (9) (2024)
Masoumeh Sharifi-Azad, Masumeh Kaveh Zenjanab, Mohammad Shahpouri, Mohammad Amin Adili-Aghdam, Marziyeh Fathi, Rana Jahanban-Esfahlan
Codelivery of methotrexate and silibinin by niosome nanoparticles for enhanced chemotherapy of CT26 colon cancer cells. Biomedical materials (Bristol, England) 19 (5) (2024)
Masumeh Kaveh Zenjanab, Nastaran Hashemzadeh, Sajjad Alimohammadvand, Masoumeh Sharifi-Azad, Elaheh Dalir Abdolahinia, Rana Jahanban-Esfahlan
Notch Signaling Suppression by Golden Phytochemicals: Potential for Cancer Therapy. Advanced pharmaceutical bulletin 14 (2) (2024)
Seyedeh Zahra Alamolhoda, Nosratollah Zarghami, Houman Kahroba, Ahmad Mehdipour, Mohammad Pourhassan-Moghaddam, Rana Jahanban-Esfahlan, Morteza Milani
Isothermal Amplification of Nucleic Acids Coupled with Nanotechnology and Microfluidic Platforms for Detecting Antimicrobial Drug Resistance and Beyond. Advanced pharmaceutical bulletin 12 (1) (2021)
Mohammad H Ayoubi-Joshaghani, Hassan Dianat-Moghadam, Khaled Seidi, Ali Jahanban-Esfahalan, Peyman Zare, Rana Jahanban-Esfahlan
Cell-free protein synthesis: The transition from batch reactions to minimal cells and microfluidic devices. Biotechnology and bioengineering 117 (4) (2020)
Melissa Emamalipour, Khaled Seidi, Ali Jahanban-Esfahlan, Rana Jahanban-Esfahlan
Implications of resistin in type 2 diabetes mellitus and coronary artery disease: Impairing insulin function and inducing pro-inflammatory cytokines. Journal of cellular physiology 234 (12) (2019)
Rana Jahanban-Esfahlan, Khaled Seidi, Masoud H Manjili, Ali Jahanban-Esfahlan, Tahereh Javaheri, Peyman Zare
Tumor Cell Dormancy: Threat or Opportunity in the Fight against Cancer. Cancers 11 (8) (2019)
Rana Jahanban-Esfahlan, Khaled Seidi, Maryam Majidinia, Ansar Karimian, Bahman Yousefi, Seyed Mohammad Nabavi, Akram Astani, Ioana Berindan Neagoe, Diana Gulei, Francesca Fallarino, Marco Gargaro, Giorgia Manni, Matteo Pirro, Jianping Weng, Mahmoud Sadeghi, Seyed Fazel Nabavi, Samira Shirooie
Toll-like receptors as novel therapeutic targets for herpes simplex virus infection. Reviews in medical virology 29 (4) (2019)